GlaxoSmithKline net profit at Rs 172 crore in Jan-Mar quarter

GlaxoSmithKline Consumer Healthcare today reported a net profit of Rs 171.71 crore for the January-March quarter.
The company had posted a net profit of Rs 156.41 crore for the same period of previous fiscal.
The company's net sales stood at Rs 1,079.09 crore for the January-March quarter, while the same was at Rs 939.86 crore in the previous fiscal, GlaxoSmithKline Consumer Healthcare (GSKCH) said in a filing to the BSE.
The company said it has changed the accounting year from January-December to April-March.
"Accordingly, current year's financial statement of the company are for a period of fifteen months...These figures are therefore not comparable with those of the previous year ended December 31, 2012," it added.

For the fifteen months ended March 31, the company posted a net profit of Rs 674.76 crore. The same stood at Rs 436.77 crore for the year ended December 31, 2012.

The company's net sales for the fifteen months ended March 31, stood at Rs 4,682.92 crore. The same stood at Rs 3,079.36 crore for the year ended December 31, 2012.
"Our robust performance for the 15 month period ending March 31, 2014 bears testament to our consistent focus on high science, market defining innovation, clutter breaking brand communication and integration of shopper insights in our sales initiatives," GSKCH Managing Director Zubair Ahmed said.

In the coming months, the company will continue to make appropriate changes to its business, including use of digital and social, to interact and engage with customers, create a culture of exceptional leaders and bring products based on high science and consumer insights, he added.
"These will future proof the organisation and help it deliver healthy growth for all stakeholders," Ahmed said.
The company's board, which met today, has recommended a dividend at the rate of Rs 45 per equity share of Rs 10 each.
GSKCH shares today closed at Rs 4,176.45 apiece on the BSE, up 0.15 per cent from the previous close.